Detalhe da pesquisa
1.
Discovery and multimerization of cross-reactive single-domain antibodies against SARS-like viruses to enhance potency and address emerging SARS-CoV-2 variants.
Sci Rep
; 13(1): 13668, 2023 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37608223
2.
Hexamerization of Anti-SARS CoV IgG1 Antibodies Improves Neutralization Capacity.
Front Immunol
; 13: 864775, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35603164